3IVU image
Deposition Date 2009-09-01
Release Date 2009-09-22
Last Version Date 2024-04-03
Entry Detail
PDB ID:
3IVU
Keywords:
Title:
Homocitrate Synthase Lys4 bound to 2-OG
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.72 Å
R-Value Free:
0.21
R-Value Work:
0.17
R-Value Observed:
0.18
Space Group:
P 62
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Homocitrate synthase, mitochondrial
Gene (Uniprot):lys4
Chain IDs:A, B
Chain Length:423
Number of Molecules:2
Biological Source:Schizosaccharomyces pombe
Primary Citation
Crystal structure and functional analysis of homocitrate synthase, an essential enzyme in lysine biosynthesis.
J.Biol.Chem. 284 35769 35780 (2009)
PMID: 19776021 DOI: 10.1074/jbc.M109.046821

Abstact

Homocitrate synthase (HCS) catalyzes the first and committed step in lysine biosynthesis in many fungi and certain Archaea and is a potential target for antifungal drugs. Here we report the crystal structure of the HCS apoenzyme from Schizosaccharomyces pombe and two distinct structures of the enzyme in complex with the substrate 2-oxoglutarate (2-OG). The structures reveal that HCS forms an intertwined homodimer stabilized by domain-swapping between the N- and C-terminal domains of each monomer. The N-terminal catalytic domain is composed of a TIM barrel fold in which 2-OG binds via hydrogen bonds and coordination to the active site divalent metal ion, whereas the C-terminal domain is composed of mixed alpha/beta topology. In the structures of the HCS apoenzyme and one of the 2-OG binary complexes, a lid motif from the C-terminal domain occludes the entrance to the active site of the neighboring monomer, whereas in the second 2-OG complex the lid is disordered, suggesting that it regulates substrate access to the active site through its apparent flexibility. Mutations of the active site residues involved in 2-OG binding or implicated in acid-base catalysis impair or abolish activity in vitro and in vivo. Together, these results yield new insights into the structure and catalytic mechanism of HCSs and furnish a platform for developing HCS-selective inhibitors.

Legend

Protein

Chemical

Disease

Primary Citation of related structures